Shimrit Mayer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shimrit Mayer has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Ruth Scherz-Shouval
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
43 shared publications - Coral Halperin
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
41 shared publications - Yaniv Stein
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
41 shared publications - Aviad Ben-Shmuel
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
21 shared publications - Dana Morzaev-Sulzbach
Chaim Sheba Medical Center, Institute of Oncology, Tel-Hashomer, Israel
21 shared publications - Debra Barki
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
21 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (4) , 916-931
Single-cell spatial atlas of the aging human breast
Breast cancer can develop over a wide age range and tumors in younger women differ from those in older women. Aging alters the spatial context of early tumors and may explain these differences, but breast tissue aging remains poorly characterized. Here, using imaging mass cytometry to profile the spatial expression of 40 proteins, we explore age-related remodeling of normal breast tissues in over 3 million cells from 527 reduction mammoplasties. Aged breast tissue was less cellular and less proliferative for all cell types (epithelial, stromal and immune). Tissue architecture was restructured with fewer heterotypic epithelial cell–cell interactions, far fewer lobules and increased fat. Older tissues had a more inflammatory microenvironment with increased M2 macrophages and granzyme B + T cells, contrasted by younger tissues in which B cells were most enriched. Our multiscale atlas extensively details an unexpected general decline of breast tissue with age and reveals its changing spatial context.
- 31 March 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (4) , 916-931
Open AccessSingle-cell spatial atlas of the aging human breast
Breast cancer can develop over a wide age range and tumors in younger women differ from those in older women. Aging alters the spatial context of early tumors and may explain these differences, but breast tissue aging remains poorly characterized. Here, using imaging mass cytometry to profile the spatial expression of 40 proteins, we explore age-related remodeling of normal breast tissues in over 3 million cells from 527 reduction mammoplasties. Aged breast tissue was less cellular and less proliferative for all cell types (epithelial, stromal and immune). Tissue architecture was restructured with fewer heterotypic epithelial cell–cell interactions, far fewer lobules and increased fat. Older tissues had a more inflammatory microenvironment with increased M2 macrophages and granzyme B + T cells, contrasted by younger tissues in which B cells were most enriched. Our multiscale atlas extensively details an unexpected general decline of breast tissue with age and reveals its changing spatial context.
- Open Access
A fibroblast-centric network drives cold fibrosis in the tumor microenvironment of lung squamous cell carcinoma
The tumor microenvironment (TME) of chronic inflammation-associated cancers (CIACs) is shaped by cycles of injury and maladaptive repair, yet the principles organizing fibrotic stroma in these tumors remain unclear. Here, we applied the concept of hot versus cold fibrosis, originally credentialed in non-cancerous fibrosis of heart and kidney, to lung squamous cell carcinoma (LUSC), a prototypical CIAC. Single-cell transcriptomics of matched tumor and adjacent-normal tissue from 16 treatment-naive LUSC patients identified a cold fibrotic architecture in the LUSC TME: cancer-associated fibroblasts (CAFs) expanded and adopted myofibroblast and stress-response states, while macrophages were depleted. This macrophage-poor, CAF-rich stroma was maintained by CAF autocrine growth factor loops, including TIMP1 , INHBA , TGFB1 , and GMFB . In parallel, the immune compartment exhibited a hot tumor phenotype with abundant T and B cells, forming spatially distinct but molecularly engaged networks with CAFs. CAF gene programs typifying cold fibrosis in LUSC were conserved in other CIACs, including esophageal and gastric adenocarcinomas. These results redefine desmoplastic regions of tumors through the lens of a non-cancer fibrosis model, demonstrating that conserved stromal circuits constitute therapeutic vulnerabilities in CIACs.
Open AccessA fibroblast-centric network drives cold fibrosis in the tumor microenvironment of lung squamous cell carcinoma
The tumor microenvironment (TME) of chronic inflammation-associated cancers (CIACs) is shaped by cycles of injury and maladaptive repair, yet the principles organizing fibrotic stroma in these tumors remain unclear. Here, we applied the concept of hot versus cold fibrosis, originally credentialed in non-cancerous fibrosis of heart and kidney, to lung squamous cell carcinoma (LUSC), a prototypical CIAC. Single-cell transcriptomics of matched tumor and adjacent-normal tissue from 16 treatment-naive LUSC patients identified a cold fibrotic architecture in the LUSC TME: cancer-associated fibroblasts (CAFs) expanded and adopted myofibroblast and stress-response states, while macrophages were depleted. This macrophage-poor, CAF-rich stroma was maintained by CAF autocrine growth factor loops, including TIMP1 , INHBA , TGFB1 , and GMFB . In parallel, the immune compartment exhibited a hot tumor phenotype with abundant T and B cells, forming spatially distinct but molecularly engaged networks with CAFs. CAF gene programs typifying cold fibrosis in LUSC were conserved in other CIACs, including esophageal and gastric adenocarcinomas. These results redefine desmoplastic regions of tumors through the lens of a non-cancer fibrosis model, demonstrating that conserved stromal circuits constitute therapeutic vulnerabilities in CIACs.
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 2 shows RNA sequencing of mouse NK cells
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 2 shows RNA sequencing of mouse NK cells
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 2 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from a 2nd of 3 biologically independent experiments
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 2 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from a 2nd of 3 biologically independent experiments
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 3 shows IHC and MxIF staining data from 72 TNBC patient TMA
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 3 shows IHC and MxIF staining data from 72 TNBC patient TMA
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 3 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is a close-up ROI of Supplementary Video 2
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 3 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is a close-up ROI of Supplementary Video 2
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Data from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 3 shows upregulation of ligands for NK cell receptors on CAFs
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 3 shows upregulation of ligands for NK cell receptors on CAFs
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 1 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from 1 of 3 biologically independent experiments
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 1 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from 1 of 3 biologically independent experiments
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 9 shows association of NK ligand expression on CAFs and patient outcomes in TNBC
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 9 shows association of NK ligand expression on CAFs and patient outcomes in TNBC